Breaking News Instant updates and real-time market news.

EIDX

Eidos Therapeutics

$23.46

-0.6 (-2.49%)

08:34
04/15/19
04/15
08:34
04/15/19
08:34

Eidos Therapeutics reports Q4 EPS (27c), consensus (25c)

The increase in net loss attributable to common stockholders was driven primarily by research and development expenses related to AG10 clinical trials and other pre-clinical studies, and general and administrative expenses for operations. Cash and cash equivalents totaled $157.1M at December 31, 2018 compared with $5.5M at December 31, 2017.

  • 22

    Apr

  • 23

    Apr

EIDX Eidos Therapeutics
$23.46

-0.6 (-2.49%)

02/27/19
ROTH
02/27/19
NO CHANGE
Target $28
ROTH
Buy
Eidos addressed stock major overhangs with smart trial design, says Roth Capital
Roth Capital analyst Yasmeen Rahimi believes that Eidos Therapeutics' ATTRibute-CM "smart trial design offers the best of both worlds" with two approvable endpoints, namely a 12-month, placebocontrolled study with primary endpoint of change from baseline in six-minute walk distance, and reduction in all-cause mortality and frequency of CV-related hospitalizations over 30 months. Overall, the analyst thinks the company has addressed the major stock overhangs with this smart design. First, by not waiting for tafamidis approval for a comparator, Eidos Therapeutics' will start its trial six months faster and shorten time to market, and second, it is now "rich in catalysts," Rahimi contends. The analyst reiterates a Buy rating and $28 price target on the shares.
02/27/19
JPMS
02/27/19
UPGRADE
Target $39
JPMS
Overweight
JPMorgan says Eidos trial design removes multiple overhangs, ups to Overweight
JPMorgan analyst Anupam Rama upgraded Eidos Therapeutics to Overweight from Neutral, citing his view that the company's design of the ATTRibute-CM study, which incorporates feedback from the FDA, removes multiple overhangs, including the need for a head-to-head study versus tafamidis and a financing overhang. The analyst, who has increased his view of the probability of success for AG10 in the ATTR-CM opportunity, also believes AG10 is likely to generate strategic interest from commercial partners. Rama raised his price target on Eidos shares to $39 from $29.
02/27/19
JPMS
02/27/19
UPGRADE
JPMS
Overweight
Eidos Therapeutics upgraded to Overweight from Neutral at JPMorgan
02/21/19
BMOC
02/21/19
INITIATION
BMOC
Outperform
Eidos Therapeutics initiated with an Outperform at BMO Capital
BMO Capital analyst George Farmer initiated Eidos Therapeutics with an Outperform rating and $28 price target. The analyst receommends buying shares as he sees huge potential for AG10 for the treatment of transthyretin amyloidosis, and estimates peak sales of $3B by 2031.

TODAY'S FREE FLY STORIES

KIDS

OrthoPediatrics

$42.95

0.95 (2.26%)

06:42
06/19/19
06/19
06:42
06/19/19
06:42
Initiation
OrthoPediatrics initiated  »

OrthoPediatrics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAF

First American

$53.10

0.41 (0.78%)

06:40
06/19/19
06/19
06:40
06/19/19
06:40
Initiation
First American initiated  »

First American initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 13

    Nov

FNF

Fidelity National

$39.85

-0.035 (-0.09%)

06:40
06/19/19
06/19
06:40
06/19/19
06:40
Initiation
Fidelity National initiated  »

Fidelity National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AUPH

Aurinia Pharmaceuticals

$6.37

0.03 (0.47%)

06:39
06/19/19
06/19
06:39
06/19/19
06:39
Hot Stocks
Aurinia Pharmaceuticals' director nominees recommended by ISS, Glass Lewis »

Aurinia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:39
06/19/19
06/19
06:39
06/19/19
06:39
Periodicals
Nissan, Renault ready to remedy corporate governance conflict, WSJ reports »

Nissan (NSANY) and…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$89.05

0.08 (0.09%)

, FDC

First Data

$26.50

-0.01 (-0.04%)

06:38
06/19/19
06/19
06:38
06/19/19
06:38
Initiation
Fiserv, First Data initiated  »

Fiserv initiated with an…

FISV

Fiserv

$89.05

0.08 (0.09%)

FDC

First Data

$26.50

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMP

Armata Pharmaceuticals

$2.81

0.005 (0.18%)

06:36
06/19/19
06/19
06:36
06/19/19
06:36
Initiation
Armata Pharmaceuticals initiated  »

Armata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NCMI

National CineMedia

$6.44

-0.03 (-0.46%)

06:35
06/19/19
06/19
06:35
06/19/19
06:35
Upgrade
National CineMedia rating change  »

National CineMedia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ARES

Ares Management

$27.30

-0.17 (-0.62%)

06:34
06/19/19
06/19
06:34
06/19/19
06:34
Hot Stocks
Ares Management-financed DCR subsidiary investing up to $165M in drilling JV »

A Development Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

APO

Apollo Global

$33.44

0.185 (0.56%)

, ARES

Ares Management

$27.30

-0.17 (-0.62%)

06:33
06/19/19
06/19
06:33
06/19/19
06:33
Hot Stocks
Chisholm Oil and Gas, Gastar Exploration announce strategic combination »

Chisholm Oil and Gas and…

APO

Apollo Global

$33.44

0.185 (0.56%)

ARES

Ares Management

$27.30

-0.17 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ADBE

Adobe

$276.80

1.21 (0.44%)

06:30
06/19/19
06/19
06:30
06/19/19
06:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$77.18

-1.35 (-1.72%)

06:28
06/19/19
06/19
06:28
06/19/19
06:28
Conference/Events
Tyson Foods to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

ENR

Energizer

$41.79

0.33 (0.80%)

, SPB

Spectrum Brands

$56.79

-0.94 (-1.63%)

06:28
06/19/19
06/19
06:28
06/19/19
06:28
Downgrade
Energizer, Spectrum Brands rating change  »

JPMorgan downgrades…

ENR

Energizer

$41.79

0.33 (0.80%)

SPB

Spectrum Brands

$56.79

-0.94 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 10

    Jul

MRK

Merck

$84.49

1.19 (1.43%)

06:27
06/19/19
06/19
06:27
06/19/19
06:27
Periodicals
Merck seeing small, midsize deals to expand cancer treatment portfolio, WSJ says »

Merck is seeking small…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 24

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 16

    Sep

  • 20

    Sep

AAPL

Apple

$198.52

4.62 (2.38%)

06:24
06/19/19
06/19
06:24
06/19/19
06:24
Periodicals
Apple explores moving 15%-30% of production capacity from China, Nikkei reports »

Apple has asked its major…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.49

1.19 (1.43%)

06:24
06/19/19
06/19
06:24
06/19/19
06:24
Conference/Events
Merck to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 24

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 16

    Sep

  • 20

    Sep

BA

Boeing

$374.21

19.31 (5.44%)

06:21
06/19/19
06/19
06:21
06/19/19
06:21
Periodicals
Concerns over pilots' strength delays 737 MAX return to flight, WSJ reports »

Plans to put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

SIX

Six Flags

$51.58

-0.44 (-0.85%)

06:20
06/19/19
06/19
06:20
06/19/19
06:20
Upgrade
Six Flags rating change  »

Six Flags upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNLN

Greenlane

$13.39

-0.29 (-2.12%)

06:20
06/19/19
06/19
06:20
06/19/19
06:20
Hot Stocks
Greenlane partners with Mary's Nutritionals to offer CBD products »

Mary's Nutritionals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, VLRS

Volaris

$9.93

0.37 (3.87%)

06:19
06/19/19
06/19
06:19
06/19/19
06:19
Hot Stocks
Indigo Partners to add 50 A321XLRs to airline fleets »

Indigo Partners and three…

EADSY

Airbus

$0.00

(0.00%)

VLRS

Volaris

$9.93

0.37 (3.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMDA

Gamida Cell

$7.50

0.5 (7.14%)

06:18
06/19/19
06/19
06:18
06/19/19
06:18
Hot Stocks
Gamida Cell, Lonza enter strategic manufacturing agreement »

Gamida Cell and Lonza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOLD

Barrick Gold

$14.38

0.21 (1.48%)

, ABGLF

Acacia Mining

$0.00

(0.00%)

06:15
06/19/19
06/19
06:15
06/19/19
06:15
Hot Stocks
Barrick Gold plans to 'engage intensively' with Acacia's minority shareholders »

Barrick Gold (GOLD)…

GOLD

Barrick Gold

$14.38

0.21 (1.48%)

ABGLF

Acacia Mining

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUE

Nucor

$52.61

1.87 (3.69%)

06:15
06/19/19
06/19
06:15
06/19/19
06:15
Conference/Events
Nucor to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GOOG

Alphabet

$1,104.40

12.15 (1.11%)

, GOOGL

Alphabet Class A

$1,105.22

12.51 (1.14%)

06:13
06/19/19
06/19
06:13
06/19/19
06:13
Hot Stocks
Google says to commit $1B to boost housing construction in Bay Area »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,104.40

12.15 (1.11%)

GOOGL

Alphabet Class A

$1,105.22

12.51 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

TRIP

TripAdvisor

$46.30

0.62 (1.36%)

06:13
06/19/19
06/19
06:13
06/19/19
06:13
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.